Cargando…
Soluble programmed cell death-ligand 1 as a new potential biomarker associated with acute coronary syndrome
BACKGROUND: Soluble programmed cell death-ligand 1 (sPD-L1) has been well documented to activate immunosuppression and is considered an essential predictor of negative clinical outcomes for several malignances and inflammatory conditions. However, the clinical significance of sPD-L1 in the periphera...
Autores principales: | Li, Shuping, Yi, Ling, Wei, Xiqing, Zhang, Jinguo, Wang, Xiaojue, Jiang, Chang, Yan, Zhuohong, Song, Liwei, Yang, Bin, Wei, Panjian, Gao, Xiang, Wang, Jinghui, Zhang, Hongtao, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478490/ https://www.ncbi.nlm.nih.gov/pubmed/36119741 http://dx.doi.org/10.3389/fcvm.2022.971414 |
Ejemplares similares
-
Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC
por: Yi, Ling, et al.
Publicado: (2023) -
Enhanced Serum IgG Detection Potential Using 38KD-MPT32-MPT64, CFP10-Mtb81-EspC Fusion Protein and Lipoarabinomannan (LAM) for Human Tuberculosis
por: Yan, Zhuohong, et al.
Publicado: (2022) -
Immunoassay with Novel Paired Antibodies for Detection of Lipoarabinomannan in the Pleural Fluid and Plasma of Patients with Tuberculous Pleurisy
por: Yan, Zhuohong, et al.
Publicado: (2023) -
CD137 ligand feedback upregulates PD‐L1 expression on lung cancer via T cell production of IFN‐γ
por: Wang, Helin, et al.
Publicado: (2019) -
Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance
por: Zhang, Junyan, et al.
Publicado: (2022)